Sofosbuvir + Velpatasvir + Voxilaprevir
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Sofosbuvir
sofosbuvir - Velpatasvir
velpatasvir - Voxilaprevir
voxilaprevir
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| Sofosbuvir 400mg / Velpatasvir 100mg / Voxilaprevir 100mg tabletsAUESGB | 400 mg / 100 mg | Gilead Sciences Ltd |
| SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIRUS | 400 mg / 100 mg | Gilead Sciences, Inc. |
| voxilaprevir + sofosbuvir + velpatasvirAU | — | — |
| 沃士維膜衣錠TW | — | 香港商吉立亞醫藥有限公司台灣分公司 |
| VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottleAU | 100 mg / 400 mg | Gilead Sciences Pty Ltd |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- CA · VOSEVI · 1 products · record
- ES · VOSEVI · 1 products · record
- GB · VOSEVI · 2 products · record
- MX · VOSEVI · 1 products · record
- US · VOSEVI · 1 products · record
- AU · VOSEVI · 1 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.